Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors
W. Sugiura et al., Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors, J HUMAN VIR, 2(3), 1999, pp. 146-153
Objective: A navel 2-amino acid insertion between codons 69 and 70 of human
immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) which con
fers multiple drug resistance has recently been reported. Independently, ar
e have identified similar insertion mutations in Japanese hemophiliacs and
attempted to analyze their emergence In conjunction with therapy regimens a
nd their contribution to drug resistance using recombinant technology.
Methods: The plasma and peripheral blood mononuclear cells (PBMCs) of 348 H
IV-1-infected hemophiliacs were screened for HIV-1 RT mutations relevant to
nucleoside analogue inhibitors and isolating viruses. Contribution of each
insertion to drug resistance was studied by introducing the mutations into
a T-cell line-tropic NL4-3 infectious clone and testing the drug susceptib
ilities of die recovered virus.
Results: Insertion of the 2-amino acid residue was found in 4 of the 348 ca
ses and was strongly associated with prolonged chemotherapy with zidovudine
(AZT) and didanosine (ddI). The virus isolated from 1 of the 4 cases posse
ssed the same insertion. Characterization of these virus and the recombinan
t: NL4-3 with the insertion strongly suggested chat the insertion caused re
sistance not only to AZT and ddI but also to lamivudine (3TC) and zalcitabi
ne (ddC).
Conclusion: A 2-amino acid insertion between codons 69 and 70 of RT was det
ected in 4 of 348 (1.1%) Japanese hemophiliacs and was found to be associat
ed with multiple drug resistance to nucleoside analogue RT inhibitors.